T0	Participants 67 117	patients with advanced non-small-cell lung cancer.
T1	Participants 311 346	patients with advanced lung cancer.
T2	Participants 490 554	Twelve patients with advanced non-small-cell lung cancer (NSCLC)
T3	Participants 803 819	¿3-(13)Călanine.
T4	Participants 820 871	Thirteen NSCLC patients and eleven healthy subjects